Estudio comparativo de costos médicos directos en el tratamiento de reproducción asistida por los métodos inseminación artificial, fecundación in vitro e invo en Colombia

Infertility is defined as an feminine reproductive system illness where a clinical pregnancy does not come to fruition after 12 months of unprotected sexual intercourses. In those cases, assisted reproduction treatments are an option among those couples who have reproductive issues and whose dream/n...

Full description

Autores:
Galindo Cortés, Jenny Catherine
Albadán Rubio, Dalia Marcela
Tipo de recurso:
Trabajo de grado de pregrado
Fecha de publicación:
2017
Institución:
Universidad de Ciencias Aplicadas y Ambientales U.D.C.A
Repositorio:
Repositorio Institucional UDCA
Idioma:
spa
OAI Identifier:
oai:repository.udca.edu.co:11158/854
Acceso en línea:
https://repository.udca.edu.co/handle/11158/854
Palabra clave:
Infertilidad
Tratamientos de reproducción asistida
Costos
Inseminación artificial
Fecundación in vitro
Método INVO
Tecnología en salud
Fertilización in vitro -- Costos
Inseminación artificial -- Costos
Tecnología reproductiva -- Costos
Rights
closedAccess
License
Derechos Reservados - Universidad de Ciencias Aplicadas y Ambientales
Description
Summary:Infertility is defined as an feminine reproductive system illness where a clinical pregnancy does not come to fruition after 12 months of unprotected sexual intercourses. In those cases, assisted reproduction treatments are an option among those couples who have reproductive issues and whose dream/necessity is to conceive a child. The treatments studied were artificial insemination, in vitro fertilization, and the INVO procedure. None of these procedures are currently covered by the colombian health-insurance plans. The total cost for artificial insemination is $5'960.00, for in vitro fertilization is $19'345.766, and for INVO procedure is $11'445.766. The high cost of these fertilization techniques could be derived from their lack of regulation, and the fact that they are not fully included in the colombian health-care system, which allows practitioners to establish the prices at their will. Also, some high impact generating events were characterized, including the use of human chorionic gonadotropin (HCG) ($355.761 COP) which corresponds to the 81.4% of the medicines' total cost; for the artificial insemination, the main procedure is the laparoscopy ($2'500.000 COP) that corresponds to the 41.9% of the treatment cost; for in vitro fertilization, including ICSN ($9'100.000 COP), that corresponds to the 47% of the treatment cost; and for INVO procedure, the main procedure is follicular aspiration ($3'800.000 COP) which corresponds to the 33.6% of the treatment's cost. When this techniques are compared by their cost-effectiveness, it is evident that the artificial insemination has a low cost, but its effectiveness is also low, which means that a lower number of women will have successful pregnancies compared with the use of the other two methods (that are more effective, but whose cost is also higher). On the other hand, we did a cost-reduction study where we compared the success of the in vitro fertilization and INVO procedures, and we discovered that that the INVO procedure is as effective as the in vitro fertilization, but its cost is lower.